Franck Gallardo

1.1k total citations
35 papers, 748 citations indexed

About

Franck Gallardo is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Franck Gallardo has authored 35 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Epidemiology and 8 papers in Genetics. Recurrent topics in Franck Gallardo's work include Cytomegalovirus and herpesvirus research (7 papers), Virus-based gene therapy research (6 papers) and CRISPR and Genetic Engineering (6 papers). Franck Gallardo is often cited by papers focused on Cytomegalovirus and herpesvirus research (7 papers), Virus-based gene therapy research (6 papers) and CRISPR and Genetic Engineering (6 papers). Franck Gallardo collaborates with scholars based in France, Canada and Germany. Franck Gallardo's co-authors include Pascal Chartrand, Kerstin Bystricky, Emmanuelle Querido, Raymund J. Wellinger, Mathieu Dalvai, David Lane, Catherine Olivier, Nancy Laterreur, Bernard Mariamé and Catherine Ménard and has published in prestigious journals such as The Journal of Cell Biology, The EMBO Journal and Molecular Cell.

In The Last Decade

Franck Gallardo

31 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franck Gallardo France 12 584 169 97 86 70 35 748
Rachel M. Mitton-Fry United States 9 783 1.3× 196 1.2× 136 1.4× 84 1.0× 63 0.9× 12 901
Hongtu Zhao China 11 760 1.3× 28 0.2× 141 1.5× 67 0.8× 56 0.8× 13 838
Alexandra M. Deaconescu United States 14 736 1.3× 33 0.2× 243 2.5× 35 0.4× 35 0.5× 23 954
Yeming Wang China 15 564 1.0× 28 0.2× 126 1.3× 55 0.6× 30 0.4× 24 691
Peter Bromley Switzerland 16 547 0.9× 34 0.2× 147 1.5× 84 1.0× 82 1.2× 33 797
Gökhan Tolun United States 14 862 1.5× 29 0.2× 193 2.0× 96 1.1× 107 1.5× 20 983
Peter Hug United States 8 442 0.8× 60 0.4× 87 0.9× 20 0.2× 46 0.7× 10 603
Janna Bednenko United States 13 813 1.4× 80 0.5× 66 0.7× 120 1.4× 17 0.2× 17 886
Morgan Tucker United States 8 1.2k 2.1× 22 0.1× 43 0.4× 92 1.1× 48 0.7× 9 1.4k
Sean P. Ryder United States 17 735 1.3× 30 0.2× 114 1.2× 33 0.4× 33 0.5× 28 864

Countries citing papers authored by Franck Gallardo

Since Specialization
Citations

This map shows the geographic impact of Franck Gallardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Gallardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Gallardo more than expected).

Fields of papers citing papers by Franck Gallardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franck Gallardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Gallardo. The network helps show where Franck Gallardo may publish in the future.

Co-authorship network of co-authors of Franck Gallardo

This figure shows the co-authorship network connecting the top 25 collaborators of Franck Gallardo. A scholar is included among the top collaborators of Franck Gallardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franck Gallardo. Franck Gallardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tollefson, Ann E., Nicolas Landrein, Vincent Roy, et al.. (2025). LAVR-289, an Orally Bioavailable Inhibitor of Adenovirus Replication In Vitro and In Vivo. ACS Infectious Diseases. 11(6). 1416–1423.
2.
Marcheteau, Elie, José Luís Fernández, Virginie Garcia, et al.. (2025). LAVR-289, an Acyclo-Nucleoside Phosphonate, Has Broad-Spectrum Activity against Herpesviruses. ACS Infectious Diseases. 11(10). 2722–2728.
3.
Yue, Lei, Gustaf E. Rydell, Maria Soller, et al.. (2025). Real-time genome imaging of host interactions in adeno-associated virus genome release. iScience. 28(6). 112624–112624. 1 indexed citations
4.
Thomas, Mathieu, Samuel Guillot, Vincent Roy, et al.. (2024). Lyotropic liquid crystal emulsions of LAVR-289: Influence of internal mesophase structure on cytotoxicity and in-vitro antiviral activity. International Journal of Pharmaceutics. 665. 124683–124683. 2 indexed citations
5.
Roy, Vincent, Patrick Favetta, Robert Snoeck, et al.. (2024). Synthesis of LAVR-289, a new [(Z)-3-(acetoxymethyl)-4-(2,4-diaminopyrimidin-6-yl)oxy-but-2-enyl]phosphonic acid prodrug with pronounced antiviral activity against DNA viruses. European Journal of Medicinal Chemistry. 271. 116412–116412. 3 indexed citations
6.
Fix, Jenna, Robin Vinck, Romain Volmer, et al.. (2023). A New Derivative of Retro-2 Displays Antiviral Activity against Respiratory Syncytial Virus. International Journal of Molecular Sciences. 25(1). 415–415. 1 indexed citations
7.
Desbois, Nicolas, Stéphane Bertagnoli, Alain Bousquet‐mélou, et al.. (2021). Antipoxvirus Activity Evaluation of Optimized Corroles Based on Development of Autofluorescent ANCHOR Myxoma Virus. ACS Infectious Diseases. 7(8). 2370–2382. 8 indexed citations
8.
Bertagnoli, Stéphane, et al.. (2021). ANCHOR-tagged equine herpesvirus 1: A new tool for monitoring viral infection and discovering new antiviral compounds. Journal of Virological Methods. 294. 114194–114194. 3 indexed citations
9.
Dusetti, Nelson, Hubert Lulka, Louis Buscail, et al.. (2021). A Novel Imaging Approach for Single-Cell Real-Time Analysis of Oncolytic Virus Replication and Efficacy in Cancer Cells. Human Gene Therapy. 32(3-4). 166–177. 5 indexed citations
10.
Gallardo, Franck, D Schmitt, Nathalie Silvestre, et al.. (2020). Fluorescent Tagged Vaccinia Virus Genome Allows Rapid and Efficient Measurement of Oncolytic Potential and Discovery of Oncolytic Modulators. Biomedicines. 8(12). 543–543. 10 indexed citations
11.
Desbois, Nicolas, et al.. (2020). A3- and A2B-fluorocorroles: synthesis, X-ray characterization and antiviral activity evaluation against human cytomegalovirus infection. RSC Medicinal Chemistry. 11(7). 783–801. 8 indexed citations
12.
Desbois, Nicolas, et al.. (2020). A3- and A2B-nitrocorroles: synthesis and antiviral activity evaluation against human cytomegalovirus infection. RSC Medicinal Chemistry. 11(7). 771–782. 8 indexed citations
13.
14.
Gallardo, Franck, et al.. (2018). Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth. Drug Design Development and Therapy. Volume 12. 2805–2814. 18 indexed citations
15.
Gros, Claude P., Nicolas Desbois, Clément Michelin, et al.. (2015). Synthesis and Antiviral Activity Evaluation of Nitroporphyrins and Nitrocorroles as Potential Agents against Human Cytomegalovirus Infection. ACS Infectious Diseases. 1(8). 350–356. 13 indexed citations
16.
Gallardo, Franck, et al.. (2014). DNA Dynamics during Early Double-Strand Break Processing Revealed by Non-Intrusive Imaging of Living Cells. PLoS Genetics. 10(3). e1004187–e1004187. 102 indexed citations
17.
Gallardo, Franck, et al.. (2011). Live Cell Imaging of Telomerase RNA Dynamics Reveals Cell Cycle-Dependent Clustering of Telomerase at Elongating Telomeres. Molecular Cell. 44(5). 819–827. 92 indexed citations
18.
Gallardo, Franck & Pascal Chartrand. (2011). Visualizing mRNAs in Fixed and Living Yeast Cells. Methods in molecular biology. 714. 203–219. 7 indexed citations
19.
Gallardo, Franck, et al.. (2008). TLC1 RNA nucleo‐cytoplasmic trafficking links telomerase biogenesis to its recruitment to telomeres. The EMBO Journal. 27(5). 748–757. 86 indexed citations
20.
Gallardo, Franck & Pascal Chartrand. (2008). Telomerase biogenesis: The long road before getting to the end. RNA Biology. 5(4). 212–215. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026